Helen Shackleford

发表

A randomised controlled trial of extended anticoagulation treatment versus standard treatment for the prevention of recurrent venous thromboembolism (VTE) and post‐thrombotic syndrome in patients being treated for a first episode of unprovoked VTE (the ExACT study)

D. Fitzmaurice, C. Bradbury, C. Heneghan, 2019, British journal of haematology.

Using DNA sequencing data to quantify T cell fraction and therapy response

Nicolai J. Birkbak, Angela E. Leek, Z. Szallasi, 2021, Nature.

A local human Vδ1 T cell population is associated with survival in nonsmall-cell lung cancer

Nicolai J. Birkbak, Angela E. Leek, Z. Szallasi, 2022, Nature Cancer.

Effect of self-monitoring and medication self-titration on systolic blood pressure in hypertensive patients at high risk of cardiovascular disease: the TASMIN-SR randomized clinical trial.

Emma P Bray, B. Williams, S. Bryan, 2014, JAMA.

Lung adenocarcinoma promotion by air pollutants

Nicolai J. Birkbak, Angela E. Leek, Z. Szallasi, 2023, Nature.

Antibodies against endogenous retroviruses promote lung cancer immunotherapy

Nicolai J. Birkbak, Angela E. Leek, Robin L. Jones, 2023, Nature.

Genomic–transcriptomic evolution in lung cancer and metastasis

Angela E. Leek, Z. Szallasi, A. Nicholson, 2023, Nature.

Evolutionary characterisation of lung adenocarcinoma morphology in TRACERx

David R. Jones, Angela E. Leek, Z. Szallasi, 2023, Nature Medicine.

Tracking early lung cancer metastatic dissemination in TRACERx using ctDNA

Angela E. Leek, Z. Szallasi, A. Nicholson, 2023, Nature.

The evolution of lung cancer and impact of subclonal selection in TRACERx

Nicolai J. Birkbak, Angela E. Leek, D. M. Miedema, 2023, Nature.

The evolution of non-small cell lung cancer metastases in TRACERx

Nicolai J. Birkbak, Angela E. Leek, Z. Szallasi, 2023, Nature.

Body composition and lung cancer-associated cachexia in TRACERx

Angela E. Leek, N. Perrimon, Z. Szallasi, 2023, Nature Medicine.

Targets and self-management for the control of blood pressure in stroke and at risk groups (TASMIN-SR): protocol for a randomised controlled trial

Emma P Bray, B. Williams, S. Bryan, 2013, BMC Cardiovascular Disorders.

University of Birmingham Targets and self-management for the control of blood pressure in stroke and at risk groups ( TASMIN-SR ) : protocol for a randomised controlled trial

Brien, Emma P Bray, B. Williams, 2017 .

Prevention and treatment of venous thromboembolism in hospital and the community: a research programme including the ExACT RCT

D. Fitzmaurice, E. Knight, C. Heneghan, 2020 .

Effect of Noninvasive Respiratory Strategies on Intubation or Mortality Among Patients With Acute Hypoxemic Respiratory Failure and COVID-19: The RECOVERY-RS Randomized Clinical Trial.

Bethany S. Jones, Max C. Richardson, Louis I. Hamilton, 2022, JAMA.

Copy number architectures define treatment-mediated selection of lethal prostate cancer clones

A. Tutt, C. Caldas, E. Provenzano, 2023, Nature communications.

University of Birmingham Effect of self-monitoring and medication self- titration on systolic blood pressure in hypertensive patients at high risk of cardiovascular disease

Emma P Bray, S. Bryan, S. Jowett, 2014 .

Effect of self-monitoring and medication self-titration on systolic blood pressure in hypertensive patients at high risk of cardiovascular disease: the TASMIN-SR randomized clinical trial.

Emma P Bray, B. Williams, S. Bryan, 2014, JAMA.

Autoimmune disease and COVID-19: a multicentre observational study in the United Kingdom

Hakeem O. Yusuff, M. Laffan, J. Kilner, 2022, Rheumatology.

Mixed responses to targeted therapy driven by chromosomal instability through p53 dysfunction and genome doubling

Nicolai J. Birkbak, Angela E. Leek, P. Van Loo, 2024, Nature communications.